Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers

NCT07319559 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Mixed Dyslipidemia

Interventions

DRUG: DW5124
DRUG: DW5124-R

Sponsor

Daewon Pharmaceutical Co., Ltd.